Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

284 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DNA Methylation and Ischemic Stroke Risk: An Epigenome-Wide Association Study.
Cullell N, Soriano-Tárraga C, Gallego-Fábrega C, Cárcel-Márquez J, Torres-Águila NP, Muiño E, Lledós M, Llucià-Carol L, Esteller M, Castro de Moura M, Montaner J, Fernández-Sanlés A, Elosua R, Delgado P, Martí-Fábregas J, Krupinski J, Roquer J, Jiménez-Conde J, Fernández-Cadenas I. Cullell N, et al. Thromb Haemost. 2022 Oct;122(10):1767-1778. doi: 10.1055/s-0042-1749328. Epub 2022 Jun 19. Thromb Haemost. 2022. PMID: 35717949
Favorable outcome of ischemic stroke in patients pretreated with statins.
Martí-Fàbregas J, Gomis M, Arboix A, Aleu A, Pagonabarraga J, Belvís R, Cocho D, Roquer J, Rodríguez A, García MD, Molina-Porcel L, Díaz-Manera J, Martí-Vilalta JL. Martí-Fàbregas J, et al. Stroke. 2004 May;35(5):1117-21. doi: 10.1161/01.STR.0000125863.93921.3f. Epub 2004 Apr 8. Stroke. 2004. PMID: 15073403
Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials.
Martí-Fàbregas J, Bravo Y, Cocho D, Martí-Vilalta JL, Díaz-Manera J, San Román L, Puig M, Blanco M, Castellanos M, Millán M, Roquer J, Obach V, Maestre J. Martí-Fàbregas J, et al. Cerebrovasc Dis. 2007;23(2-3):85-90. doi: 10.1159/000097043. Epub 2006 Nov 15. Cerebrovasc Dis. 2007. PMID: 17114877
KCNK17 genetic variants in ischemic stroke.
Domingues-Montanari S, Fernández-Cadenas I, Del Río-Espinola A, Mendioroz M, Fernandez-Morales J, Corbeto N, Delgado P, Ribó M, Rubiera M, Obach V, Martí-Fàbregas J, Freijo M, Serena J, Montaner J. Domingues-Montanari S, et al. Atherosclerosis. 2010 Jan;208(1):203-9. doi: 10.1016/j.atherosclerosis.2009.07.023. Epub 2009 Jul 31. Atherosclerosis. 2010. PMID: 19647252
Association of a genetic variant in the ALOX5AP with higher risk of ischemic stroke: a case-control, meta-analysis and functional study.
Domingues-Montanari S, Fernández-Cadenas I, del Rio-Espinola A, Corbeto N, Krug T, Manso H, Gouveia L, Sobral J, Mendioroz M, Fernández-Morales J, Alvarez-Sabin J, Ribó M, Rubiera M, Obach V, Martí-Fàbregas J, Freijo M, Serena J, Ferro JM, Vicente AM, Oliveira SA, Montaner J. Domingues-Montanari S, et al. Cerebrovasc Dis. 2010;29(6):528-37. doi: 10.1159/000302738. Epub 2010 Mar 30. Cerebrovasc Dis. 2010. PMID: 20357438
Role of the MMP9 gene in hemorrhagic transformations after tissue-type plasminogen activator treatment in stroke patients.
Fernández-Cadenas I, Del Río-Espínola A, Carrera C, Domingues-Montanari S, Mendióroz M, Delgado P, Rosell A, Ribó M, Giralt D, Quintana M, Castellanos M, Obach V, Martínez S, Freijo MM, Jiménez-Conde J, Roquer J, Martí-Fábregas J, Molina CA, Alvarez-Sabín J, Montaner J. Fernández-Cadenas I, et al. Stroke. 2012 May;43(5):1398-400. doi: 10.1161/STROKEAHA.111.639823. Epub 2012 Apr 10. Stroke. 2012. PMID: 22496335
284 results